Studies found that CD4+ T lymphocytes and the TGF‐β1/MAPK signaling pathway are involved in valve tissue hyperplasia and fibrotic lesions in rheumatic heart disease.25 The gene discussed is TGFB1; the disease is rheumatic heart disease.